A new trading day began on Tuesday, with Quest Diagnostics, Inc. (NYSE: DGX) stock price up 0.03% from the previous day of trading, before settling in for the closing price of $155.92. DGX’s price has ranged from $123.04 to $160.95 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 4.86% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 2.20%. With a float of $111.07 million, this company’s outstanding shares have now reached $111.61 million.
In an organization with 48000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 16.01%, operating margin of 13.59%, and the pretax margin is 11.67%.
Quest Diagnostics, Inc. (DGX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Quest Diagnostics, Inc. is 0.49%, while institutional ownership is 89.24%. The most recent insider transaction that took place on Oct 28 ’24, was worth 278,450. Before that another transaction happened on Aug 29 ’24, when Company’s SVP & General Counsel sold 32,551 for $154.97, making the entire transaction worth $5,044,516. This insider now owns 38,478 shares in total.
Quest Diagnostics, Inc. (DGX) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 2.15 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.50% during the next five years compared to 7.36% growth over the previous five years of trading.
Quest Diagnostics, Inc. (NYSE: DGX) Trading Performance Indicators
Here are Quest Diagnostics, Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.82. Likewise, its price to free cash flow for the trailing twelve months is 17.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.45, a number that is poised to hit 2.19 in the next quarter and is forecasted to reach 9.72 in one year’s time.
Technical Analysis of Quest Diagnostics, Inc. (DGX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.94 million. That was better than the volume of 0.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 62.18%. Additionally, its Average True Range was 3.31.
During the past 100 days, Quest Diagnostics, Inc.’s (DGX) raw stochastic average was set at 80.42%, which indicates a significant increase from 64.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.06% in the past 14 days, which was higher than the 21.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $153.20, while its 200-day Moving Average is $140.15. However, in the short run, Quest Diagnostics, Inc.’s stock first resistance to watch stands at $157.28. Second resistance stands at $158.60. The third major resistance level sits at $159.76. If the price goes on to break the first support level at $154.80, it is likely to go to the next support level at $153.64. Assuming the price breaks the second support level, the third support level stands at $152.32.
Quest Diagnostics, Inc. (NYSE: DGX) Key Stats
With a market capitalization of 17.41 billion, the company has a total of 111,615K Shares Outstanding. Currently, annual sales are 9,252 M while annual income is 854,000 K. The company’s previous quarter sales were 2,488 M while its latest quarter income was 226,000 K.
